Gabelli Securities »

Terns Pharmaceuticals shares owned by Gabelli Securities

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 206k 52.72

More positions owned by Gabelli Securities

Electronic Arts Equity (EA)
Chart Industries Equity (GTLS)
Sealed Air Corp Equity
Warner Bros Discovery Equity (WBD)
Hologic Equity
Txnm Energy Equity (TXNM)
Clearwater Analytics Hds-a Equity
Arcellx Equity (ACLX)
Penumbra Equity (PEN)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Masimo Corp Equity
Gdl Fund Exchange Traded (GDL)
Norfolk Southern Corp Equity (NSC)
Air Lease Corp Equity
Kenvue Equity (KVUE)

View all positions for Gabelli Securities

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
venBio Select Advisor
Vanguard Capital Management
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management
Glazer Capital
Paradigm Biocapital Advisors

View all funds holding Terns Pharmaceuticals